Dr. Jolene K. Berg

Family Medicine
308 Dearborn Court, 
Edina, MN 
308 Dearborn Court, 
Edina, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jolene Berg is a primary care provider, practicing in Family Medicine in Edina, Minnesota. Her top areas of expertise are Chronic Kidney Disease, Type 2 Diabetes (T2D), and End-Stage Renal Disease (ESRD).

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Family Medicine
Licenses
Family Medicine in MN
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

308 Dearborn Court, Edina, MN 55343

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Phase 1 Pharmacokinetics and Safety Study of Oral Soticlestat in Participants With Moderate or Mild Hepatic Impairment and Normal Hepatic Function
Phase 1 Pharmacokinetics and Safety Study of Oral Soticlestat in Participants With Moderate or Mild Hepatic Impairment and Normal Hepatic Function
Enrollment Status: Completed
Publish Date: February 02, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on the Single-Dose Pharmacokinetics of Sitravatinib
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on the Single-Dose Pharmacokinetics of Sitravatinib
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Subjects With Severely Impaired Renal Function
A Phase 1, Open-label, Single-dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Subjects With Severely Impaired Renal Function
Enrollment Status: Completed
Publish Date: June 23, 2022
Intervention Type: Drug
Study Phase: Phase 1
An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function
An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function
Enrollment Status: Completed
Publish Date: December 10, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of MEK162 in Subjects With Mild, Moderate and Severe Hepatic Impairment
A Phase I, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of MEK162 in Subjects With Mild, Moderate and Severe Hepatic Impairment
Enrollment Status: Terminated
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Non-randomized, Parallel-group, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects
A Phase 1, Non-randomized, Parallel-group, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects
Enrollment Status: Completed
Publish Date: February 18, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

16 Total Publications

Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19.
Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19.
Journal: Journal of clinical pharmacology
Published: April 26, 2023
Similar Doctors
Expertise in
11
conditions
Dr. David M. Ross
Family Medicine
Expertise in
11
conditions
Dr. David M. Ross
Family Medicine

Park Nicollet Clinic

3800 Park Nicollet Blvd, Mailstop 61n01i, 
St Louis Park, MN 
 (2.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Ross is a primary care provider, practicing in Family Medicine in St Louis Park, Minnesota. Dr. Ross is highly rated in 11 conditions, according to our data. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Myelofibrosis, Leukemia, Myeloproliferative Neoplasms (MPN), and Endoscopy. Dr. Ross is currently accepting new patients.

Expertise in
6
conditions
Dr. John E. Hokanson
Family Medicine
Expertise in
6
conditions
Dr. John E. Hokanson
Family Medicine

Group Health Plan Inc

1500 Curve Crest W Blvd, 
Stillwater, MN 
 (28.7 miles away)
651-439-1234
Experience:
10+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Hokanson is a primary care provider, practicing in Family Medicine in Stillwater, Minnesota. Dr. Hokanson has been practicing medicine for over 10 years is highly rated in 6 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Coronary Heart Disease, and Type 1 Diabetes (T1D). Dr. Hokanson is currently accepting new patients.

Expertise in
10
conditions
Dr. Won S. Choi
Family Medicine
Expertise in
10
conditions
Dr. Won S. Choi
Family Medicine

Fairview Clinics

1440 Duckwood Dr, 
Eagan, MN 
 (12.6 miles away)
651-406-8860
Languages Spoken:
English, Korean
See accepted insurances
Accepting New Patients
Offers Telehealth

Won Choi is a primary care provider, practicing in Family Medicine in Eagan, Minnesota. Dr. Choi is highly rated in 10 conditions, according to our data. His top areas of expertise are Flu, Shingles, Avian Influenza, and COVID-19. Dr. Choi is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Berg's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile